Bristol Myers Squibb (BMY) Prepaid Assets (2009 - 2026)

Bristol Myers Squibb has disclosed Prepaid Assets across 18 years of filings, most recently posting $4.6 billion for Q1 2026.

• In Q1 2026, Prepaid Assets fell 16.93% year-over-year to $4.6 billion; the TTM figure through Mar 2026 stood at $4.6 billion (down 16.93% YoY), while the FY2025 annual figure was $4.6 billion, down 17.87% from the prior year.
• Prepaid Assets was little changed at $4.6 billion in Q1 2026, from $4.6 billion in the prior quarter.
• Over the last five years, Prepaid Assets for BMY reached as high as $7.2 billion in Q3 2023 and fell as low as $4.5 billion in Q1 2022.
• The 5-year median for Prepaid Assets is $5.6 billion (2024), against an average of $5.6 billion.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 39.11% — and 2024, when it fell 21.98%.
• A 5-year view of Prepaid Assets shows it stood at $5.8 billion in 2022, then increased by 1.93% to $5.9 billion in 2023, then retreated by 4.91% to $5.6 billion in 2024, then slipped by 17.87% to $4.6 billion in 2025, then dropped by 0.35% to $4.6 billion in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $4.6 billion, $4.6 billion, and $4.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.